BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 8534695)

  • 1. Infection rates in end-stage renal disease patients treated with CCPD and CAPD using the UltraBag system.
    Ghahramani N; Gorban-Brennan N; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1995; 11():164-7. PubMed ID: 8534695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis.
    Holley JL; Bernardini J; Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):133-6. PubMed ID: 2382649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD).
    de Fijter CW; Oe PL; Nauta JJ; van der Meulen J; ter Wee PM; Snoek FJ; Donker AJ
    Adv Perit Dial; 1991; 7():186-9. PubMed ID: 1680422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.
    Luvira V; Satirapoj B; Supasyndh O; Chaiprasert A; Ruangkanchanasetr P; Nata N; Kanjanakul I; Supaporn T; Choovichian P; Bijaphala S; Luvira U; Phiboonbanakit D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S30-6. PubMed ID: 22043564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritonitis - does peritoneal dialysis modality make a difference?
    Piraino B; Sheth H
    Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
    Kavanagh D; Prescott GJ; Mactier RA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of peritoneal dialysis-related infections in CAPD patients with diabetes mellitus.
    Lye WC; Leong SO; van der Straaten JC; Lee EJ
    Adv Perit Dial; 1993; 9():195-7. PubMed ID: 8105922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
    Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
    Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of peritonitis in patients on automated peritoneal dialysis.
    Yishak A; Bernardini J; Fried L; Piraino B
    Adv Perit Dial; 2001; 17():205-8. PubMed ID: 11510277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD.
    Wong HS; Ong LM; Lim TO; Hooi LS; Morad Z; Ghazalli R; Shaariah W; Lim YN; Ahmad G; Goh BL; Liaw L; Pee S; Lee ML
    Am J Kidney Dis; 2006 Sep; 48(3):464-72. PubMed ID: 16931220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.
    Borg D; Shetty A; Williams D; Faber MD
    Adv Perit Dial; 2003; 19():202-5. PubMed ID: 14763063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of infectious peritonitis of CAPD patients in Rajavithi Hospital.
    Bunnag S; Thanakitcharu P; Krairittichai U; Jirajan B; Meenune W; Kanjanapanth C
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S37-43. PubMed ID: 22043565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance in CAPD and CCPD patients as measured by supply inventories during home visits.
    Bernardini J; Piraino B
    Am J Kidney Dis; 1998 Jan; 31(1):101-7. PubMed ID: 9428459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis.
    Finkelstein ES; Jekel J; Troidle L; Gorban-Brennan N; Finkelstein FO; Bia FJ
    Am J Kidney Dis; 2002 Jun; 39(6):1278-86. PubMed ID: 12046042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis in children undergoing dialysis. 10 years experience.
    Levy M; Balfe JW; Geary DF; Fryer-Keene SP; Bannatyne RM
    Child Nephrol Urol; 1988-1989; 9(5):253-8. PubMed ID: 3271590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single center success with a high risk peritoneal dialysis population.
    Dumler F; Schmidt RJ; Cruz C; Faber M; Zasuwa G
    Adv Perit Dial; 1992; 8():105-7. PubMed ID: 1361761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous cyclic peritoneal dialysis--is it worth the extra effort?
    Domoto DT; Weindel ME
    Adv Perit Dial; 1989; 5():212-5. PubMed ID: 2577414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.